Date | Dividend Yield | Free Cash Flow Yield | Earnings Yield | Enterprise Value (EV) |
---|
CEO | Mr. Kevin R. Thornal |
IPO Date | Nov. 6, 2014 |
Location | United States |
Headquarters | 1800 Bridge Parkway |
Employees | 1,215 |
Sector | Health Care |
Industries |
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It also provides 10 kHz Therapy, which delivers neuromodulation solutions for treating chronic pain based on available clinical evidence. The company sells its products through its direct sales force, and a network of sales agents and independent distributors. Nevro Corp. was incorporated in 2006 and is headquartered in Redwood City, California.
Past 5 years
USD 10.28
USD 17.51
USD 147.95
USD 11.84
USD 3.15
USD 35.55
USD 16.15
USD 67.79
USD 47.63
USD 57.52
USD 31.05
USD 138.83
USD 23.55
USD 30.08
USD 6.84
StockViz Staff
January 15, 2025
Any question? Send us an email